4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-201468
Options or other derivatives
- Director acquired 64,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lehrer-Graiwer Joshua Director | 2026-04-23 | Grant or award · Stock Option (right to buy) | +64,000 | 64,000 | D | ||
Loading xslF345X06/ownership.xml…